Stella Mook

Stella Mook

UNVERIFIED PROFILE

Are you Stella Mook?   Register this Author

Register author
Stella Mook

Stella Mook

Publications by authors named "Stella Mook"

Are you Stella Mook?   Register this Author

29Publications

658Reads

41Profile Views

Restaging after chemoradiotherapy for locally advanced esophageal cancer.

Ann Transl Med 2019 Dec;7(Suppl 8):S288

Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2019.11.57DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976470PMC
December 2019

Frequency of surgical resection after starting neoadjuvant chemoradiotherapy in patients with esophageal cancer: A population-based cohort study.

Eur J Surg Oncol 2019 Oct 27;45(10):1919-1925. Epub 2019 Mar 27.

Department of Surgery, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S07487983193036
Publisher Site
http://dx.doi.org/10.1016/j.ejso.2019.03.031DOI Listing
October 2019

Role of neoadjuvant chemoradiotherapy in clinical T2N0M0 esophageal cancer: A population-based cohort study.

Eur J Surg Oncol 2018 05 13;44(5):620-625. Epub 2018 Feb 13.

Department of Surgery, University Medical Center, Utrecht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejso.2018.02.005DOI Listing
May 2018

Radiation to the Gastric Fundus Increases the Risk of Anastomotic Leakage After Esophagectomy.

Ann Thorac Surg 2016 12 17;102(6):1798-1804. Epub 2016 Oct 17.

Department of Surgery, University Medical Center, Utrecht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2016.08.027DOI Listing
December 2016

Independent prognostic value of screen detection in invasive breast cancer.

J Natl Cancer Inst 2011 Apr 24;103(7):585-97. Epub 2011 Feb 24.

Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djr043DOI Listing
April 2011

Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature.

Ann Surg Oncol 2010 May 22;17(5):1406-13. Epub 2010 Jan 22.

Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-009-0902-xDOI Listing
May 2010

The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer.

Breast Cancer Res Treat 2010 Apr 5;120(3):655-61. Epub 2010 Mar 5.

Division of Diagnostic Oncology, Netherlands Cancer Institute, Plesmanlaan, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-0814-2DOI Listing
April 2010

MammaPrint 70-gene profile quantifies the likelihood of recurrence for early breast cancer.

Expert Opin Med Diagn 2009 Mar;3(2):193-205

Université Libre de Bruxelles, Jules Bordet Institute, Department of Medical Oncology, Boulevard de Waterloo 125, 1000 Brussels, Belgium + 32 2 541 3082 ; + 32 2 538 0858 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17530050902751618DOI Listing
March 2009

Clinical application of the 70-gene profile: the MINDACT trial.

J Clin Oncol 2008 Feb;26(5):729-35

Jules Bordet Institute, Blvd de Waterloo, 125, 1000 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.14.3222DOI Listing
February 2008

Individualization of therapy using Mammaprint: from development to the MINDACT Trial.

Cancer Genomics Proteomics 2007 May-Jun;4(3):147-55

Netherlands Cancer Institute, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
November 2007

Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial.

Nat Clin Pract Oncol 2006 Oct;3(10):540-51

Medical Oncology & Translational Research, Jules Bordet Institute, Boulevard de Waterloo 125, 1000 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncponc0591DOI Listing
October 2006